Claims
- 1-15 (canceled).
- 16: A process for producing 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde, which comprises:
converting a carboxyl group in 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyric acid to a formyl group.
- 17: The process as defined in claim 16, wherein said 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyric acid is produced by converting a halogen atom in 3-(3-halogeno-4-methoxyphenyl)-3-methylbutyric acid to a hydroxyl group.
- 18: The process as defined in claim 17, wherein said 3-(3-halogeno-4-methoxyphenyl)-3-methylbutyric acid is prepared by reacting a 2-halogenoanisole with 3-methylcrotonic acid.
- 19: The process as defined in claim 17, wherein said halogen atom is a chlorine atom or a bromine atom.
- 20: The process as defined in claim 18, wherein said reacting of a 2-halogenoanisole with 3-methylcrotonic acid comprises reacting in the presence of an acid.
- 21 The process as defined in claim 16, wherein said converting a carboxyl group into a formyl group comprises reducing a carboxylic acid directly to an aldehyde; or converting a carboxyl group into a hydroxymethyl group and converting said hydroxymethyl group into a formyl group.
- 22: A process for producing N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which comprises:
reductively alkylating 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde obtained by the process of claim 16 with aspartame
- 23: A process for producing N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which comprises:
reductively alkylating 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde with aspartame.
- 24: A compound of formula (3):
- 25: A compound selected from the group consisting of
3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde; 3-(3-chloro-4-methoxyphenyl)-3-methylbutyric acid; 3-(3-bromo-4-methoxyphenyl)-3-methylbutyric acid; 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyric acid; and 3-(3-hydroxy-4-methoxyphenyl)-3-methyl-1-butanol.
- 26: A process for producing N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which comprises:
subjecting N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester containing impurity to crystallize the compound crystallization.
- 27: The process as defined in claim 26, wherein said N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester containing impurity is obtained by reductively akylating aspartame and 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde or a derivative thereof.
- 28: The process as defined in claim 26, wherein said impurity is one or more compounds selected from the group consisting of aspartame, an aspartame derivative, a peptide derivative, an amino acid, an amino acid derivative, an aldehyde and an aldehyde derivative.
- 29: The process as defined in claim 26, wherein a solvent used in the crystallization is selected from the group consisting of methanol, ethanol, isopropyl alcohol, acetone, methyl ethyl ketone, methyl isobutyl ketone, methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, tetrahydrofuran, acetonitrile, toluene, mixtures thereof; and mixtures thereof with water.
- 30: The process as defined in claim 26, further comprising removing said impurity from said N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester by extracting said impurity with a solvent.
- 31: The process as defined in claim 30, wherein said solvent is selected from the group consisting of toluene, diethyl ether, chloroform, dichloromethane, hexane, ethyl acetate, propyl acetate, isopropyl acetate and butyl acetate.
- 32: A crystal of N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which exhibits X-ray diffraction peaks at at least diffraction angles of 8.3°, 19.5° and 21.2° (2θ, CuKcαray) when examined by powder X-ray diffractometry.
- 33: A sweetening composition comprising the crystal of N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester as defined in claim 32 and a carrier or bulking agent.
- 34: A food or drink comprising the crystal as defined in claim 32 as an effective ingredient.
- 35: A process for sweetening a food or drink, comprising
adding the crystal as defined in claim 32 to a food, a beverage, or an intermediate product used for making the food or beverage, in an amount sufficient to sweeten said food or drink.
Priority Claims (4)
Number |
Date |
Country |
Kind |
11-288207 |
Oct 1999 |
JP |
|
11-288208 |
Oct 1999 |
JP |
|
11-294409 |
Oct 1999 |
JP |
|
11-328099 |
Nov 1999 |
JP |
|
CROSS-REFERENCE TO RELATED APPLICATION
[0001] The present application is a continuation application of PCT/JP00/06933 filed Oct. 4, 2000, the entire contents of which are incorporated by reference.
Divisions (1)
|
Number |
Date |
Country |
Parent |
10117205 |
Apr 2002 |
US |
Child |
10862426 |
Jun 2004 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/JP00/06933 |
Oct 2000 |
US |
Child |
10117205 |
Apr 2002 |
US |